INTRODUCTION: Acute ST elevation myocardial infarction (STEMI) occurs most commonly when thrombus formation causes occlusion of a major coronary vessel. Thrombolytic therapy is a signicant advancement in the treatment of STEMI. Clinical trials have established the safety and efcacy of thrombolytic therapy in STEMI when administered within 12 hours of the onset of symptoms; the earlier it is administered, the greater the benet. METHODOLOGY: A Cross-sectional observational study was carried out at Sir T. Hospital, Bhavnagar. 100 Acute STEMI (ST elevation myocardial infarction) patients admitted in ICCU during august 2021 to July 2022 after taking informed written consent were subjected to detailed history and complete physical examination and data collected was noted in a predesigned Performa. Among 100 patients, majority of the cases were in age group of 51 to 60 yrs RESULTS: . Male patients are predominantly affected than female patients. IV Streptokinase thrombolytic therapy in acute STEMI pa CONCLUSION: tients within golden hours improved the reperfusion of myocardium and also associated with reduction of adverse events and decreased mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.